DIN 02565226 — LUNSUMIO 1 MG
LUNSUMIO is a solution of Mosunetuzumab marketed by HOFFMANN-LA ROCHE LIMITED. The full Mosunetuzumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02565226
- Brand name
- LUNSUMIO
- Active ingredient
- Mosunetuzumab
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- CD20 x CD3 bispecific monoclonal antibody (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mosunetuzumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02567377 | LUNSUMIO SC | 45 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02567369 | LUNSUMIO SC | 5 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |